AHG Announces Initiation of World-Class, Proprietary Brain-Computer Interface R&D Program - Targeting the Next Frontier of Human Neurotechnology

Akso Health Group announced the launch of a proprietary Brain-Computer Interface R&D program aimed at establishing a new long-term growth engine. The company is pursuing innovations in neural sensing and AI decoding with pending patents, though it has not commenced human clinical trials or made FDA submissions.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.